Subscribe: MedWorm: Ankylosing Spondylitis
http://www.medworm.com/rss/medicalfeeds/conditions/Ankylosing-Spondylitis.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
ankylosing spondylitis  ankylosing  arthritis  medical news  medpage today  new  news  patients  source  spondylitis  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Ankylosing Spondylitis

MedWorm: Ankylosing Spondylitis News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Ankylosing Spondylitis



Last Build Date: Tue, 13 Feb 2018 17:27:18 +0100

 



Factors Affecting Blood Loss During Total Hip Arthroplasty in Patients With Ankylosing Spondylitis

Wed, 17 Jan 2018 16:27:44 +0100

No abstract available (Source: Lippincott's Bone and Joint Newsletter)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Novartis advances head-to-head superiority trials of Cosentyx ® versus Humira®* and proposed biosimilar adalimumab**

Tue, 09 Jan 2018 09:00:00 +0100

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondylitis (AS). SURPASS is the first head-to-head clinical trial in AS investigating superiority of Cosentyx in slowing spinal bone damage versus proposed biosimilar adalimumab**. SURPASS is currently recruiting patients, with the 'first patient first visit' already achieved in November 2017. (Source: World Pharma News)



Anti-IL17 Benefits Persist in Spine Disease (CME/CE)

Wed, 27 Dec 2017 15:30:00 +0100

(MedPage Today) -- Rapid responses seen for secukinumab in ankylosing spondylitis (Source: MedPage Today Primary Care)



Juliette and Kirran explain what working on our campaign has meant to them

Thu, 23 Nov 2017 14:35:31 +0100

Arthritis Research UK’sThe Nation’s Joint Problem campaign has reached millions of people over the last three months, through national news stories and features and TV, cinema and billboard advertising. We asked two people who helped to shape the campaign content about their experience of being part of our ground-breaking push to change attitudes to arthritis.JulietteJournalist and author ofMostly Cloudy, Some Bright Spells Juliette Wills, 45, has lived with inflammatory spinal arthritis for 18 years. She wrote thesix powerful stories featured in The Guardian which exposed the hidden impact of arthritis, as well as talking frankly on camera about how arthritis has affected her own life. Juliette says: "I was commissioned because Arthritis Research UK knew it was important to wo...



Patients' drugs fail to arrive  at their homes

Tue, 14 Nov 2017 11:02:41 +0100

The 42-year-old teacher has ankylosing spondylitis — a type of inflammatory arthritis which mainly affects the spine — and has been treating it with injections of etanercept since 2009. (Source: the Mail online | Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




The patients left in despair as drugs fail to arrive  

Tue, 14 Nov 2017 00:51:04 +0100

The 42-year-old teacher has ankylosing spondylitis — a type of inflammatory arthritis which mainly affects the spine — and has been treating it with injections of etanercept since 2009. (Source: the Mail online | Health)



Golimumab Gets FDA Nod for Two New Indications Golimumab Gets FDA Nod for Two New Indications

Tue, 24 Oct 2017 19:18:53 +0100

The TNF-alpha inhibitor significantly improved the signs and symptoms of psoriatic arthritis and ankylosing spondylitis in phase 3 testing.FDA Approvals (Source: Medscape Medical News Headlines)



Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis

Sat, 21 Oct 2017 02:35:46 +0100

SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis (Source: Johnson and Johnson)



FDA Approves Simponi Aria (golimumab) for the Treatment of Adults With Active Psoriatic Arthritis or Active Ankylosing Spondylitis

Fri, 20 Oct 2017 02:10:38 +0100

Horsham, Pa., October 20, 2017 ― Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab), the only fully-human anti-tumor necrosis factor (TNF)-alpha therapy administered via a... (Source: Drugs.com - New Drug Approvals)



Inflammatory Spinal Disorders Common in IBD Patients Inflammatory Spinal Disorders Common in IBD Patients

Fri, 22 Sep 2017 20:13:12 +0100

Ankylosing spondylitis (AS), axial spondyloarthritis (SpA) and inflammatory back pain are common in inflammatory bowel disease (IBD) patients two decades after IBD diagnosis, according to findings from the IBSEN study.Reuters Health Information (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Ankylosing Spondylitis Quiz: Symptoms & Treatment

Wed, 20 Sep 2017 07:00:00 +0100

Title: Ankylosing Spondylitis Quiz: Symptoms& TreatmentCategory: MedicineNet QuizCreated: 1/16/2013 12:00:00 AMLast Editorial Review: 9/20/2017 1:05:25 PM (Source: MedicineNet Arthritis General)



Tofacitinib in Patients With Ankylosing Spondylitis Tofacitinib in Patients With Ankylosing Spondylitis

Tue, 12 Sep 2017 04:14:29 +0100

How do different doses of tofacitinib compare in terms of safety and efficacy?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)



What Are the Side Effects of Prednisone for Ankylosing Spondylitis?

Tue, 29 Aug 2017 07:00:00 +0100

Title: What Are the Side Effects of Prednisone for Ankylosing Spondylitis?Category: Doctor's& Expert's views on SymptomsCreated: 8/29/2017 12:00:00 AMLast Editorial Review: 8/29/2017 12:00:00 AM (Source: MedicineNet Arthritis General)



Back pain and fatigue? Symptoms could be warning sign of THIS form of arthritis

Mon, 21 Aug 2017 09:01:40 +0100

ARTHRITIS - inflammation of the joints - and back pain, are symptoms of long term chronic condition Ankylosing spondylitis . (Source: Daily Express - Health)



New study highlights key quality of life factors for ankylosing spondylitis

Wed, 16 Aug 2017 23:00:00 +0100

A new study has shed light on some of the most prevalent modifiable factors that predict a poor quality of life in people withankylosing spondylitis. Moreover, the University of Aberdeen research indicated that some of these factors - which include pain,fatigue and poor physical function - are currently better monitored than others, suggesting new approaches to treating this painful condition may be needed. The most important predictors for poor quality of life The study analysed data from 959 patients involved in the Scotland Registry for Ankylosing Spondylitis, which collected clinical and patient-reported data on ankylosing spondylitis from across Scotland. A total of five factors were identified as independent predictors of a poor quality of life among patients: moderate to severe fati...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Anesthesia for Hip Replacement in Ankylosing Spondylitis Anesthesia for Hip Replacement in Ankylosing Spondylitis

Wed, 26 Jul 2017 04:14:45 +0100

Anesthesia management in ankylosing spondylitis is challenging. This case series presents a novel analgesia protocol for total hip replacement in patients with ankylosing spondylitis.BMC Anesthesiology (Source: Medscape Today Headlines)



Merck launches biosimilar version of J & J blockbuster Remicade

Mon, 24 Jul 2017 16:06:31 +0100

Merck and Co. Inc. on Monday became the second pharmaceutical company to launch a biosimilar version of Remicade, a drug that generates billions of dollars a year in sales for Johnson& Johnson. Renflexis, the Merck biosimilar product, was approved by the Food and Drug Administration on April 21 as a treatment for rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis. It is the first medicine available in the United States under a global biosimilars develop ment and… (Source: bizjournals.com Health Care News Headlines)



Statins Linked to Reduced Mortality in Ankylosing Spondylitis Statins Linked to Reduced Mortality in Ankylosing Spondylitis

Fri, 21 Jul 2017 03:58:17 +0100

Patients with ankylosing spondylitis who began taking a statin had a 37% reduction in mortality compared with similar patients who did not take statins.Medscape Medical News (Source: Medscape Medical News Headlines)



Statins May Lengthen Life in AS (CME/CE)

Tue, 18 Jul 2017 19:45:00 +0100

(MedPage Today) -- Over 30% drop in all-cause mortality patients with ankylosing spondylitis (Source: MedPage Today Cardiovascular)



7 medtech stories we missed this week: June 30, 2017

Fri, 30 Jun 2017 20:01:49 +0100

[Image from unsplash.com]From ConforMIS touting its knee replacement study to Consulting Radiologists’s new breast cancer detection tool, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Study: Low-dose CT scanning improves Ankylosing Spondylitis assessment A new study has shown that low-dose computed tomography (LD-CT) is more sensitive than X-rays for monitoring disease progression in people who have Ankylosing Spondylitis, according to a June 15 press release. LD-CT has previously been proven to be sensitive and reliable when assessing bone growth in different patients. The new study is designed to compare how well it can show the formation of new bony growth (syndesmophytes) and an increase in size in syndesmophytes. The study showed...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Anti - TNF - α Rx Improves Sleep Quality in Ankylosing Spondylitis

Sat, 24 Jun 2017 00:00:00 +0100

Patients see reduction in PSQI scores, but no change in polysomnography parameters (Source: Pulmonary Medicine News - Doctors Lounge)



Novartis reports favourable data from Phase III extension trial of Cosentyx for AS

Sun, 18 Jun 2017 23:00:00 +0100

Novartis has reported positive results from the Phase III MEASURE 1 extension trial of Cosentyx (secukinumab) to treat patients with active ankylosing spondylitis (AS). (Source: Drug Development Technology)



Low-dose CT scanning improves assessment of ankylosing spondylitis patients

Thu, 15 Jun 2017 04:00:00 +0100

(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 showed that low dose computed tomography is more sensitive than conventional radiographs (X-rays) in the monitoring of disease progression in patients with Ankylosing Spondylitis (AS). (Source: EurekAlert! - Medicine and Health)



Medical News Today: Best exercises and postures for ankylosing spondylitis

Sat, 10 Jun 2017 10:00:00 +0100

Following an exercise routine can help people with ankylosing spondylitis manage their symptoms and slow the progression of the condition. (Source: Health News from Medical News Today)



State of Musculoskeletal Health 2017

Wed, 31 May 2017 23:00:00 +0100

We are delighted to announce the launch of theState of Musculoskeletal Health 2017.The compendium report, to be updated annually, is a comprehensive one-stop data source of information and statistics on the prevalence, incidence, risk factors, comorbidities and impact of the most prevalent musculoskeletal conditions in the UK. What conditions are included?1. Inflammatory conditionsAxial Spondyloarthritis (including ankylosing spondylitis)GoutJuvenile idiopathic arthritisRheumatoid arthritis2. Musculoskeletal painOsteoarthritisBack pain3. Osteoporosis and fragility fracturesThe State of Musculoskeletal Health 2017 document is a resource for health professionals, policy makers, public health leads and anyone interested in musculoskeletal health.We believe that with the best informa...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




State of Musculoskeletal Health 2017 report

Wed, 31 May 2017 23:00:00 +0100

We are delighted to announce the launch of theState of Musculoskeletal Health 2017 report.The compendium report, to be updated annually, is a comprehensive one-stop data source of information and statistics on the prevalence, incidence, risk factors, comorbidities and impact of the most prevalent musculoskeletal conditions in the UK. What conditions are included?1. Inflammatory conditionsAxial Spondyloarthritis (including ankylosing spondylitis)GoutJuvenile idiopathic arthritisRheumatoid arthritis2. Musculoskeletal painOsteoarthritisBack pain3. Osteoporosis and fragility fracturesThe State of Musculoskeletal Health 2017 document is a resource for health professionals, policy makers, public health leads and anyone interested in musculoskeletal health.We believe that with the ...



Arthritis symptoms - CURE on the horizon for this painful condition

Tue, 30 May 2017 11:01:46 +0100

ARTHRITIS - inflammation of the joints and back pain - are symptoms of long term chronic condition Ankylosing spondylitis . (Source: Daily Express - Health)



Medical News Today: Ankylosing spondylitis: Pictures, early signs, and progression

Mon, 29 May 2017 13:00:00 +0100

in this article, learn about ankylosing spondylitis which is a type of arthritis. What are the symptoms, how is it diagnosed, and how might it be treated? (Source: Health News from Medical News Today)



Medical News Today: Diet tips for managing ankylosing spondylitis

Wed, 24 May 2017 16:00:00 +0100

What foods and nutrients are beneficial for ankylosing spondylitis and what foods should be avoided? What supplements are recommended? (Source: Health News from Medical News Today)



Medical News Today: Ankylosing spondylitis: Symptoms and early signs

Tue, 23 May 2017 07:00:00 +0100

Ankylosing spondylitis may begin in the spine but what is it, what are the symptoms, and how is it diagnosed? What are the causes and complications? (Source: Health News from Medical News Today)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Medical News Today: Ankylosing spondylitis: Progression and outlook

Mon, 22 May 2017 16:00:00 +0100

Ankylosing spondylitis is a chronic disorder that causes pain, stiffness, and inflammation. Learn about how it affects the body as it progresses. (Source: Health News from Medical News Today)



Medical News Today: Ankylosing spondylitis: Tests, diagnosis, and treatment

Thu, 18 May 2017 16:00:00 +0100

In this article, we look at the questions and tests used to diagnose ankylosing spondylitis, which causes chronic pain in the lower back and buttocks. (Source: Health News from Medical News Today)



Medical News Today: Nine possible complications of ankylosing spondylitis

Thu, 18 May 2017 10:00:00 +0100

What is ankylosing spondylitis and what are the associated complications? What are the rarer complications and how might it be treated? (Source: Health News from Medical News Today)



Medical News Today: Ankylosing spondylitis: X-ray and imaging techniques

Thu, 18 May 2017 07:00:00 +0100

X-rays and imaging techniques are essential for diagnosing ankylosing spondylitis, an inflammatory condition that affects the back and sacroiliac joints. (Source: Health News from Medical News Today)



New study highlights role of common gene variations in ankylosing spondylitis

Mon, 15 May 2017 23:00:00 +0100

New research has revealed an insight into the genetic underpinnings ofankylosing spondylitis that could aid the future treatment of the disease. Led by the University of Oxford and published in the Proceedings of the National Academy of Sciences, the study has indicated that the specific genetic variants associated with the onset of the condition may be more common than previously thought. The true genetic origin of ankylosing spondylitis For this study, data on 213 ankylosing spondylitis patients and 46 people with rheumatoidarthritis was analysed in order to examine the common scientific assumption that ankylosing spondylitis is mostly associated with unusual ERAP1 genotypes. It is known that two genes involved in antigen processing and presentation to the immune system - HLA-B*27 and ER...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




BSR: Lower Tx Dose in Ankylosing Spondylitis Possible (CME/CE)

Tue, 02 May 2017 18:35:02 +0100

(MedPage Today) -- Dose reduction may mean substantial savings with minimal clinical risk (Source: MedPage Today Pain Management)



European Commission Approves AMGEVITA ™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases

Thu, 23 Mar 2017 20:00:10 +0100

First Biosimilar Adalimumab Approved in the European Union THOUSAND OAKS, Calif., March 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for AMGEVITA™ (biosimilar adalimumab1) in all available indications. AMGEVITA is authorized for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidence of AS; moderate-to-severe chronic plaque psoriasis; moderate-to-severe hidradenitis suppurativa; non-infectious intermediate, posterior and panuve... (Source: Amgen News Release)



Study Examines Characteristics of Psoriatic Spondyloarthritis in Psoriatic Arthritis With Ankylosing Spondylitis

Sat, 18 Mar 2017 09:39:33 +0100

No abstract available (Source: Lippincott's Bone and Joint Newsletter)



Secukinumab Benefits Hold Up for 2 Years (CME/CE)

Mon, 06 Mar 2017 15:50:45 +0100

(MedPage Today) -- In ankylosing spondylitis, no new safety signals emerged (Source: MedPage Today Rheumatology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




The risk of depression, suicidal ideation, and suicide attempt in patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis - Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, Egeberg A, Liu J, Simon G.

Thu, 23 Feb 2017 04:15:15 +0100

BACKGROUND: Sparse information is available concerning mental health issues in psoriasis, psoriatic arthritis (PsA), and ankylosing spondylitis (AS) patients. OBJECTIVE: To estimate risk of depression, suicidal ideation, and suicide attempt in pati... (Source: SafetyLit)



NSAIDs Plus TNF Inhibitors May Slow Damage in Ankylosing Spondylitis

Sun, 19 Feb 2017 01:23:48 +0100

No abstract available (Source: Lippincott's Bone and Joint Newsletter)



Spine Concepts, Low Back Pain

Sat, 11 Feb 2017 15:37:58 +0100

Acute low back pain or low back pain with sciatica radiating to the lower leg and to the foot (Figure 1). They are initially treated conservatively for at least six weeks by physical therapy, anti-inflammatory medication and limited activity (as guided by the pain). Doctors should treat the condition conservatively. Even if there is a large disc herniation on the MRI, unless the disc is central or causing a neurological deficit, they need wait at least six weeks before beginning a more aggressive treatment. 90% of patients will have symptoms that resolve in one month. Smoking, depression and vibrations will increase the incidence of low back pain (Figure 2). Intradiscal pressure (IDP) will change depending on the position (Figure 3). The lowest pressure is measured while the pati...



Marker Predicts IBD in Spine Disease (CME/CE)

Fri, 03 Feb 2017 18:35:02 +0100

(MedPage Today) -- Elevated fecal calprotectin linked with later Crohn's in ankylosing spondylitis (Source: MedPage Today Gastroenterology)



Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases

Fri, 27 Jan 2017 12:40:28 +0100

First Adalimumab Biosimilar Candidate Recommended for EMA Approval THOUSAND OAKS, Calif., Jan. 27, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of ABP 501 (biosimilar adalimumab), recommending approval for all available indications. ABP 501 has been recommended for approval for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis (AS), severe axial spondyloarthritis without radiographic evidence of AS, moder... (Source: Amgen News Release)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Indonesian woman's rigid spine from Ankylosing Spondylitis

Thu, 19 Jan 2017 00:10:05 +0100

Pictures show 35-year-old Sulami a woman from the Sragen area of Central Java, in the grip of a disease that has turned her completely rigid. (Source: the Mail online | Health)



Benefits of Secukinumab in Ankylosing Spondylitis May Persist at Two Years Benefits of Secukinumab in Ankylosing Spondylitis May Persist at Two Years

Tue, 17 Jan 2017 20:49:20 +0100

Secukinumab appears to improve clinical and radiographic outcomes of ankylosing spondylitis (AS) through two years of therapy, according to new results from the MEASURE 1 study.Reuters Health Information (Source: Medscape Orthopaedics Headlines)






Combination Therapy May Slow Progression of Ankylosing Spondylitis

Fri, 16 Dec 2016 13:34:02 +0100

No abstract available (Source: Lippincott's Bone and Joint Newsletter)



Statins Cut Mortality in Seronegative Spondyloarthropathies Statins Cut Mortality in Seronegative Spondyloarthropathies

Mon, 14 Nov 2016 20:37:31 +0100

Patients with ankylosing spondylitis or psoriatic arthritis might benefit from statin treatment, a new study shows.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




New Phase 3 Data Show Simponi Aria ® (Golimumab) Significantly Improved Signs And Symptoms In Patients With Active Ankylosing Spondylitis

Mon, 14 Nov 2016 17:39:00 +0100

Patients with Painful Inflammatory Spinal Arthritis Showed Marked Improvements in Multiple Study Endpoints Following Treatment with SIMPONI ARIA ® (Source: Johnson and Johnson)



Combination of NSAIDs and TNF-inhibitors shows benefit for ankylosing spondylitis

Sun, 13 Nov 2016 20:47:59 +0100

A combination of nonsteroidal anti-inflammatory drugs and TNF-inhibitors may help slow down spine damage in ankylosing spondylitis, according to new research findings. (Source: ScienceDaily Headlines)



Fine-Tuning Treatment for Ankylosing Spondylitis (CME/CE)

Sun, 13 Nov 2016 18:00:00 +0100

(MedPage Today) -- Focus is on specific clinical situations, and hope now is for guideline update in light of new options (Source: MedPage Today Pain Management)



AS: Is Xeljanz the Next Big Thing? (CME/CE)

Sun, 13 Nov 2016 16:00:00 +0100

(MedPage Today) --'Field of ankylosing spondylitis management has suddenly come alive'(Source: MedPage Today Primary Care)



AS: Is Tofacitinib the Next Big Thing? (CME/CE)

Sun, 13 Nov 2016 16:00:00 +0100

(MedPage Today) --'Field of ankylosing spondylitis management has suddenly come alive'(Source: MedPage Today Rheumatology)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Medical News Today: Statins could cut death risk by a third for some arthritis patients

Sun, 13 Nov 2016 08:00:00 +0100

Researchers find statins could lower the risk of death for patients with psoriatic arthritis and ankylosing spondylitis by reducing inflammation. (Source: Health News from Medical News Today)



Ankylosing Spondylitis and fibromyalgia: Woman describes treatment 'life-changing'

Mon, 07 Nov 2016 12:31:00 +0100

A WOMAN who suffers from debilitating illnesses Ankylosing Spondylitis and Fibromyalgia has found a way of easing her pain which she has described as 'life-changing'. (Source: Daily Express - Health)



RheumNow: POSTURE Study

Tue, 01 Nov 2016 22:35:04 +0100

(MedPage Today) -- Apremilast fails in ankylosing spondylitis (Source: MedPage Today Primary Care)



FDA Approves Amgen's AMJEVITA ™ (Adalimumab-Atto) For Treatment Of Seven Inflammatory Diseases

Fri, 23 Sep 2016 22:05:57 +0100

First Regulatory Approval for Company's Biosimilar Portfolio First Biosimilar Adalimumab Approved by FDA THOUSAND OAKS, Calif., Sept. 23, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved AMJEVITA™ (adalimumab-atto) across all eligible indications of the reference product, Humira® (adalimumab). AMJEVITA is the first adalimumab biosimilar approved by the FDA and has been approved for the treatment of seven inflammatory diseases, including moderate-to-severe rheumatoid arthritis, moderate-to-severe polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, moderate-to-severe chronic plaqu... (Source: Amgen News Release)



Unique Gut Microbiome Triggers AS, Research Hints Unique Gut Microbiome Triggers AS, Research Hints

Tue, 20 Sep 2016 19:19:19 +0100

The differences in gut bacteria between carriers of the spondyloarthritis-linked HLA-B27 gene and noncarriers suggest a possible causative role in ankylosing spondylitis (AS), investigators report.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Imaging Reliability Varies in Ankylosing Spondylitis Imaging Reliability Varies in Ankylosing Spondylitis

Tue, 20 Sep 2016 05:14:04 +0100

The first direct comparison of the three modes of imaging in ankylosing spondylitis showed that some methods are better than others at detecting structural changes in ankylosing spondylitis.Medscape Medical News (Source: Medscape Medical News Headlines)



Combo Therapy Slows Progression in Ankylosing Spondylitis Combo Therapy Slows Progression in Ankylosing Spondylitis

Sun, 18 Sep 2016 15:42:40 +0100

Radiologic progression of ankylosing spondylitis is significantly slower when a TNF inhibitor is added to high-dose NSAIDs, new research shows, but clinicians agree that more research is needed.Medscape Medical News (Source: Medscape Medical News Headlines)



Higher Risk for Kidney Stones in Ankylosing Spondylitis (CME/CE)

Mon, 29 Aug 2016 18:35:02 +0100

(MedPage Today) -- Consistent with higher rate of comorbidities in general (Source: MedPage Today Rheumatology)



Mysterious Back Pain and The Sacroiliac Joint

Wed, 24 Aug 2016 19:30:36 +0100

Low back pain is very common and often the the sacroiliac joint is source of that pain. However pain originating from SI joint is usually unappreciated, underdiagnosed, misunderstood and usually contributes to other sources such as in the hip and spine. Patients experiencing low back pain can spend months or even years in treatment without the correct diagnosis. Diagnostic injection of the sacroiliac joint is the only means to confirm diagnosis. Pain from the hips, spine and SI joint can overlap and be associated. Patients can experience injuries associated with the spine and SI joint or the hip and SI joint. If the patient has a back sprain and it doesn't improve for several months, it is important to look at the SI joints. The SI joints are weight bearing joints. These joints dis...



Conditions with Confusing Names

Thu, 18 Aug 2016 20:11:14 +0100

Spondylolysis, Spondylolisthesis, Spondylitis & Spondylosis These four conditions affect the lumbar spine and may be confusing. What is the difference between spondylolysis, spondylolisthesis, spondylitis, and spondylosis? Spondylolysis (pars interarticularis Defect) - Used to describe the anatomic defect or break of the pars interarticularis of the vertebral arch. Spondylolysis usually occurs in the lower lumbar spine, especially the L5 vertebrae. It usually appears as a radiolucent gap on lateral X-ray. It occurs in about 5% of the population; it is not present at birth but develops over time and may run in families. Spondylolysis is usually caused due to repetitive trauma, especially hyperextension. Repetitive trauma may cause stress fractures. The condition is usually asymptomati...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




The Latest in Lupus, Arthritis, and Ankylosing Spondylitis The Latest in Lupus, Arthritis, and Ankylosing Spondylitis

Wed, 10 Aug 2016 16:46:05 +0100

A productive meeting in London yields important new results in rheumatoid arthritis, ankylosing spondylitis, and lupus. Dr Ioannis Parodis gives an overview of his top studies.Medscape Rheumatology (Source: Medscape Today Headlines)



Ankylosing Spondylitis

Wed, 27 Jul 2016 07:00:00 +0100

Title: Ankylosing Spondylitis < br / > Category: Diseases and Conditions < br / > Created: 12/31/1997 12:00:00 AM < br / > Last Editorial Review: 7/27/2016 12:00:00 AM (Source: MedicineNet Arthritis General)



Ankylosing Spondylitis, Radiologic Perspective

Mon, 18 Jul 2016 07:00:00 +0100

(Source: eMedicineHealth.com)



Pharma jousts statistically for an ankylosing spondylitis edge

Fri, 01 Jul 2016 16:01:35 +0100

Now that the interleukin-17 inhibitor secukinumab and tumor necrosis factor inhibitors are competing options for treatment of patients with ankylosing spondylitis, the companies that make those drugs... (Source: Family Practice News)



Ankylosing Spondylitis, Ophthalmologic Perspective

Thu, 16 Jun 2016 07:00:00 +0100

Eye Problems Caused by Ankylosing Spondylitis (Source: eMedicineHealth.com)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Understanding Ankylosing Spondylitis Medications

Thu, 16 Jun 2016 07:00:00 +0100

Ankylosing Spondylitis Medications (Source: eMedicineHealth.com)



Oral JAK Inhibitor Promising in Ankylosing SpondylitisOral JAK Inhibitor Promising in Ankylosing Spondylitis

Thu, 09 Jun 2016 20:31:00 +0100

The first study to assess the safety and efficacy of tofacitinib in ankylosing spondylitis suggests that JAK inhibition might be a new way to achieve control in patients with active disease. Medscape Medical News (Source: Medscape Medical News Headlines)



IL-17A Blockade Halts Damage to Spine in AS (CME/CE)

Thu, 09 Jun 2016 17:14:36 +0100

(MedPage Today) -- Over 2 years, 80% of patients with ankylosing spondylitis treated with secukinumab had no progression (Source: MedPage Today Meeting Coverage)



IL-17A Blockade May Halt Spine Damage in AS (CME/CE)

Thu, 09 Jun 2016 17:14:36 +0100

(MedPage Today) -- Over 2 years, 80% of patients with ankylosing spondylitis treated with secukinumab had no progression (Source: MedPage Today Rheumatology)



Secukinumab may slow structural ankylosing spondylitis progression

Thu, 09 Jun 2016 15:29:50 +0100

LONDON – Long-term treatment with the interleukin 17A inhibitor secukinumab showed suggestive evidence of inhibiting structural progression of spinal disease in 168 patients with ankylosing... (Source: Family Practice News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Ankylosing Spondylitis, Orthopedic Perspective

Tue, 17 May 2016 07:00:00 +0100

(Source: eMedicineHealth.com)



Two new trustees recruited to help drive our changing strategy

Wed, 11 May 2016 23:00:00 +0100

We’re pleased to announce that we’ve appointed two new trustees to our board. Professor Sallie Lamb will contribute her primary care and therapy expertise while Alex Hesz will be adding his digital experience. The new appointments will help us in our plans to expand our activities to include personalised information content and an enhanced enquiries service, and to extend our influencing activities. Alex Hesz Alex Hesz, executive interactive director at adam&eveDDB, joined the start-up as its first head of digital, having returned to London from the US where he was managing director of Modernista. His expertise in digital content and marketing will help the organisation to achieve its aspirations around personalised content and finding and engaging more people with arthrit...



Neck Fractures May Be Lethal in Spine Disease (CME/CE)

Wed, 11 May 2016 20:00:00 +0100

(MedPage Today) -- Thirteen-fold increase in mortality after cervical spine fracture in ankylosing spondylitis (Source: MedPage Today Primary Care)



Ankylosing Spondylitis, Neurologic Perspective

Mon, 09 May 2016 07:00:00 +0100

(Source: eMedicineHealth.com)



Ankylosing Spondylitis, Rheumatologic Perspective

Mon, 09 May 2016 07:00:00 +0100

(Source: eMedicineHealth.com)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Early Statin Therapy May Lower CVD Risk With Ankylosing SpondylitisEarly Statin Therapy May Lower CVD Risk With Ankylosing Spondylitis

Wed, 04 May 2016 19:45:27 +0100

In patients with ankylosing spondylitis (AS), early statin therapy decreases arterial wall inflammation and may lower cardiovascular disease (CVD) risk, a pilot study suggests. Reuters Health Information (Source: Medscape Medical News Headlines)



IL-17 Blocker Helps in AS Quality of Life (CME/CE)

Tue, 26 Apr 2016 20:41:54 +0100

(MedPage Today) -- Secukinumab effective in patient-reported outcomes in ankylosing spondylitis (Source: MedPage Today Pain Management)



Study highlights work disruptions caused by ankylosing spondylitis

Thu, 31 Mar 2016 23:00:00 +0100

New research has shed light on the potentially serious disruptions that ankylosing spondylitis patients experience in their working lives.Led by Maastricht University in the Netherlands, the study has indicated that the working difficulties patients this inflammatory condition of the spine can cause often grow worse over time, as well as highlighting key factors that play a role in this process.Analysing working trends in the long-term The researchers aimed to examine the impact of ankylosing spondylitis on work disability over 12 years compared with the general population, while also exploring the specific factors that can predict adverse work outcomes.Data from 215 patients was taken from an international study that included patients from the Netherlands, France and Belgium, with results...



Secukinumab in ankylosing spondylitis or psoriatic arthritis: Added benefit not proven

Fri, 18 Mar 2016 04:00:00 +0100

(Institute for Quality and Efficiency in Health Care) Drug manufacturer presented no relevant data and claimed no added benefit. Notable was the non-publication of literature searches and analyses. (Source: EurekAlert! - Medicine and Health)



Novartis’ Cosentyx® superior to Stelara in delivering lasting skin clearance for psoriasis patients

Wed, 09 Mar 2016 10:49:51 +0100

Cosentyx launched as first-line systemic indication for psoriasis in UK in 2015 and recently approved for psoriatic arthritis and ankylosing spondylitis in Europe (Source: Pharmacy Europe)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Ankylosing Spondylitis: Data Support 6-Month Trial of TNFisAnkylosing Spondylitis: Data Support 6-Month Trial of TNFis

Thu, 03 Mar 2016 12:00:16 +0100

The effect of TNF inhibitors on ankylosing spondylitis reached maximum efficacy and stabilized only after 6 months of treatment, twice the time recommended in widely followed guidelines. Medscape Medical News (Source: Medscape Medical News Headlines)



New drugs recommended for ankylosing spondylitis and nr-axSpA treatment in the NHS

Mon, 15 Feb 2016 00:00:00 +0100

The National Institute for Health and Care Excellence (NICE) is a government body that decides which drugs and treatments are available on the NHS in England and Wales. A number of anti-TNF therapies have now been recommended for use within the NHS as treatments for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis (nr-axSpA). Non-radiographic axial spondyloarthritis differs from ankylosing spondylitis, as there is no X-ray evidence of structural damage, meaning it can often go unrecognised for years. New guidance issued by NICE has endorsed the therapies as options for patients who have failed to respond to other forms of treatment, opening up new avenues for those affected by the most severe forms of the disease. New recommendations The guidance recommend...



New guidelines for treatment of ankylosing spondylitis

Mon, 01 Feb 2016 00:00:00 +0100

(Source: PharmacoEconomics and Outcomes News)



Study shows long-term benefits of golimumab therapy for psoriatic arthritis

Fri, 29 Jan 2016 00:00:00 +0100

New research has demonstrated the potentially significant long-term benefits that golimumab therapy can provide for people with psoriatic arthritis.The international study, led by the University of California, San Diego, aimed to evaluate long-term outcomes in psoriatic arthritis patients who achieved or did not achieve minimal disease activity over five years of golimumab treatment.This placebo-controlled trial lasted 24 weeks and was followed by an open-label extension period of up to five years. Results from the study were published in the medical journal Arthritis Care and Research.It was shown that treatment with golimumab yielded significantly higher response rates in terms of achieving minimal disease activity levels compared to those on placebo at weeks 14, 24 and 52, with minimal ...



Biosimilar of Remicade Works in Ankylosing Spondylitis (CME/CE)

Wed, 27 Jan 2016 13:30:00 +0100

(MedPage Today) -- No differences in immunogenicity were observed, authors say (Source: MedPage Today Geriatrics)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Gut bacteria could lead to new treatment for inflammatory arthritis

Thu, 21 Jan 2016 00:00:00 +0100

Studying the trillions of bacteria and other microbes that share our body space could lead to a preventative treatment for immune diseases such as rheumatoid arthritis. It's long been suggested that the bacteria which live in our gut, mouth and elsewhere on our bodies may affect our immune system and lead to the development of certain diseases, including rheumatoid arthritis. But exactly how changes to these bacteria, collectively called the “microbiome”, cause disease remains to be discovered. The research, which we awarded £2 million to, aims to unlock the link between gut bacteria and the development of immune diseases. This programme award brings together an international team of researchers, led by the University of Oxford, with partners from Birmingham and Universit...



Secukinumab receives FDA approval for psoriatic arthritis, ankylosing spondylitis

Mon, 18 Jan 2016 20:02:46 +0100

The Food and Drug Administration approved two new indications for the interleukin-17A inhibitor secukinumab (Cosentyx) – psoriatic arthritis in adults and ankylosing spondylitis in adults – on Jan. 15. These join the approval for moderate to severe plaque psoriasis in adults it received in January... (Source: Skin and Allergy News)



US FDA approves Cosentyx for ankylosing spondylitis and psoriatic arthritis treatment

Mon, 18 Jan 2016 00:00:00 +0100

Swiss drug maker Novartis has secured approvals from the US Food and Drug Administration (FDA) for injectable medication Cosentyx for two new indications, which can now be used to treat patients having ankylosing spondylitis (AS) and psoriatic arthri… (Source: Pharmaceutical Technology)



Novartis receives two new FDA approvals for Cosentyx(R) (secukinumab) to treat patients with ankylosing spondylitis and psoriatic arthritis

Sat, 16 Jan 2016 04:00:00 +0100

Cosentyx is the first and only interleukin-17A (IL-17A) antagonist approved for adult patients with active ankylosing spondylitis (AS) and psoriatic arthritis (PsA) Approvals for both indications based on efficacy and safety outcomes shown across four P... Biopharmaceuticals, FDANovartis, Cosentyx, secukinumab, psoriasis, ankylosing spondylitis, arthritis (Source: HSMN NewsFeed)



Novartis Receives FDA Approval for Cosentyx (secukinumab) to Treat Patients with Ankylosing Spondylitis and Psoriatic Arthritis

Fri, 15 Jan 2016 22:01:04 +0100

EAST HANOVER, N.J., Jan. 15, 2016 Novartis announced today that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and... (Source: Drugs.com - New Drug Approvals)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Poor Bone Structure Common in AS Patients (CME/CE)

Thu, 07 Jan 2016 16:34:45 +0100

(MedPage Today) -- Abnormalities may help explain fractures in ankylosing spondylitis (Source: MedPage Today Rheumatology)



Pregnancy Problems Common With Spine Disease (CME/CE)

Tue, 29 Dec 2015 14:50:04 +0100

(MedPage Today) -- C-section, preeclampsia, preterm birth frequent in women with ankylosing spondylitis (Source: MedPage Today Primary Care)



Study: Not All axSpA Progresses to Ankylosing Spondylitis (CME/CE)

Sun, 27 Dec 2015 18:35:05 +0100

(MedPage Today) -- Axial spondyloarthritis may be a prolonged prodromal state, authors say (Source: MedPage Today Rheumatology)



New Drug for Severe Form of Arthritis Shows Promise in Trial

Fri, 25 Dec 2015 05:16:40 +0100

Already approved to treat psoriasis, higher dose of Cosentyx helped 60 percent of patients Source: HealthDay Related MedlinePlus Pages: Ankylosing Spondylitis, Medicines (Source: MedlinePlus Health News)



Secukinumab cut ankylosing spondylitis symptoms in MEASURE trials

Wed, 23 Dec 2015 22:00:00 +0100

Secukinumab, an interleukin 17-A inhibitor approved for the treatment of moderate to severe psoriasis, significantly reduced the signs and symptoms of ankylosing spondylitis in two phase III trials, researchers reported Dec. 23 in the New England Journal of Medicine. The results of the... (Source: Skin and Allergy News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




On-Demand Doses of Infliximab in Ankylosing SpondylitisOn-Demand Doses of Infliximab in Ankylosing Spondylitis

Wed, 02 Dec 2015 17:00:00 +0100

Would ankylosing spondylitis patients benefit from a treatment regimen of on-demand maintenance dosing with infliximab? Journal of Clinical Rheumatology (Source: Medscape Orthopaedics Headlines)